PharmaGap Inc.
Symbol:
GAP
Exchange:
TSX-Venture
Industry:
Consumer Products
Products:
Biotechnology/Pharmaceuticals
Company Website: Click Here
Company Info: Click Here
Quote and News: Click Here
Profiled Price:
$0.19
(November 13)
Company Snapshot:
PharmaGap Inc., based in Ottawa, ON, is a biotechnology company with a core focus on developing novel peptide therapeutics for the treatment of cancer. PharmaGap's GAP-107B8 is a novel peptide drug designed to inhibit the activity of protein kinase C (PKC), a cell signalling enzyme implicated in certain types and stages of cancer. Independent peer-reviewed research has demonstrated that over-expression of PKC plays a role in the development of many cancer types.
|
